Co-funded by the European Union, the UK Research and Innovation and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027
The #CTGCT at @kemijski is opening two new positions to strengthen our work in quality systems and cell & gene therapy development.
1️⃣ QC Expert (Assistant with a Doctorate) Deadline: 29 June 2026
2️⃣ Assistant‑S Deadline: 1 July 2026
Link: https://t.co/NQOA6BTG3d
#hiring#GCT
Imamo izziv: Kako lahko preboji na področju genskih in celičnih terapij hitreje, varneje in pravičneje pridejo do pacientov.
@gcuzak#ZOPS je vodil okroglo mizo v sklopu znanstvenega simpozija “Od funkcijske genomike do genske terapije”
@_CTGCT_@ULMF_pr@kemijski@AgencijaJAZMP
Final reminder: GeneH & CFGBC Scientific Symposium
3 June 2026 | Ljubljana.
Gene therapy, rare diseases, functional genomics & patient-focused round table.
Programme:
https://t.co/kuH4uQcjIH
#GeneH#GeneTherapy
Why do some tumors respond to immunotherapy while others don’t?
Join the next #CTGCT#ScienceTalks with Peter Brazda from @UMCUtrecht on 3D co‑culture models and tumor–immune interactions.
1 June 2026 14:00
https://t.co/hubKiCUgZO
#Immunotherapy
CTGCT at BioFair 5.0 🇸🇮
Our team met with students to talk careers, skills, and the future of gene & cell therapy in Slovenia.
From CTGCT’s mission to the @GeneH_project and a round table on rare genetic diseases. A full day of exchange and discussion.
https://t.co/KKkQWKlvfR
Vabljeni na našo razstavo ob 80. obletnici na prostem 𝗨𝘀𝘁𝘃𝗮𝗿𝗷𝗮𝗺𝗼 𝘇𝗮 𝗶𝘇𝘇𝗶𝘃𝗲 𝗽𝗿𝗶𝗵𝗼𝗱𝗻𝗼𝘀𝘁𝗶, ki bo na ogled do 𝟮𝟰. 𝗷𝘂𝗻𝗶𝗷𝗮 𝟮𝟬𝟮𝟲 na 𝗞𝗿𝗮𝗸𝗼𝘃𝘀𝗸𝗲𝗺 𝗻𝗮𝘀𝗶𝗽𝘂.
Razstavo je omogočil Turizem Ljubljana.
#kemijski#80let#znanost#raziskave #ljubljana
Next CTGCT Science Talk | 1 June, 14:00 CEST
Peter Brazda explores how 3D co‑culture models and multimodal tumor immunology workflows can unravel tumor–immune interactions—and inform next‑generation T‑cell therapies.
Read more and join the webinar: https://t.co/hubKiCUgZO
Dr Thomas Fox, @uclmedsci, shared insights on programmable T‑cell therapies at the latest @_CTGCT_ Science Talks, exploring CRISPR gene editing, lipid nanoparticles & the future of immune cells as “living medicines.”
🔗Read more: https://t.co/gmjeUT8b9j
#GeneEditing#CellTherapy
𝗧𝗵𝗲 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗼𝗳 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 𝗶𝘀 𝗵𝗶𝗿𝗶𝗻𝗴!
We are looking for a 𝗚𝗠𝗣 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗲𝘅𝗽𝗲𝗿𝘁 at @_CTGCT_ – Center for the Technologies of Gene and Cell Therapy (m/f).
Send your application, including a CV and cover letter, by 𝗝𝘂𝗻𝗲 𝟲, 𝟮𝟬𝟮𝟲.
👉 https://t.co/CbTFzm4DMf
More info: 01/4760 236, Dr. Darja Marolt Presen
#career #ctgct #chemistry #job
We’re recruiting!
We’re looking for an Assistant with a Doctorate (GMP expert) to join our team.
🧪 PhD in life sciences | GMP & GxP focus
📅 Apply by: 6 June 2026
Learn more about the role and how to apply :
https://t.co/FoAP1bFcED
#Hiring#GMP#LifeSciences
We welcomed Dr. Thomas Fox (@harvardmed & @ucl) to discuss how CRISPR‑engineered T cells could become living medicines. From fixing faulty immune “brakes” to creating stealth cells and in‑vivo programming.
Read more: https://t.co/x3m8w2vVny
#CRISPR#CellTherapy#Immunotherapy
The biggest challenge in #GeneTherapy? Turning breakthroughs into therapies that patients can actually access. In our new #GeneH video, partners talk about costs, regulation, manufacturing and how a 4-helix hub can help bridge the gap.
Watch:https://t.co/V7xSA1FDsJ
Still time to submit your abstract for the GeneH & 21st CFGBC Scientific Symposium in Ljubljana. Present your work in the poster session and join researchers in genomics, gene therapy & rare diseases.
https://t.co/ELQNKs2Wlw
#GeneH#CFGBC#PosterSession#GeneTherapy#RareDiseases
Progress in gene & cell therapy doesn’t happen in isolation. It grows through cross‑disciplinary dialogue, critical evaluation of new technologies & discussion of challenges
Contribute to #CTGCTDay2026 programme and help shape where the field is heading
https://t.co/wM176BF3eN
Our team attended a one‑day symposium on the latest developments in #Cell & #GeneTherapy, from CAR‑T beyond oncology to in vivo gene therapy and advanced imaging.
We also met with @ucl partners to discuss future collaboration.
Read more: https://t.co/DhybkWgRcn
Are you working in gene, cell or tissue therapy?
#CTGCTDay2026 we just opened our call for oral and poster contributions! Open to MSc students, PhDs, postdocs, clinicians, industry scientists & professors.
📅Submit by 15.07.2026
📍Ljubljana, 11.11.2026
🔗https://t.co/wM176BF3eN
We are looking forward to this presentation by our colleague Dr Duško Lainšček as part of the #symposium we are organising in collaboration with the #CFGBC.
Don't miss it
Link: https://t.co/T5Z2ykmvO9
Meet invited speaker Dr Duško Lainšček at the GeneH & 21st CFGBC Scientific Symposium in Ljubljana. He will present: “AAV9-Mediated Gene Replacement Therapy for CTNNB1-Related Neurodevelopmental Disorder.”
Learn more: https://t.co/ELQNKs2Wlw
#GeneH#CFGBC#GeneTherapy#CTNNB1
We are looking forward to the presentation of Prof Rajvinder Karda from the Institute for Women’s Health, @ucl, UK.
If you don't want to miss her presentation and many more, don't forget to register for the #GeneH & 21st CFGBC Scientific #Symposium
Link: https://t.co/T5Z2ykmvO9
Meet invited speaker Prof Rajvinder Karda at the GeneH & 21st CFGBC Scientific Symposium in Ljubljana. She will present: “AAV Based Genetic Therapies for Severe Childhood Genetic Neurological Disorders.” Learn more:
https://t.co/Cl5dF3NEb0
#GeneH#CFGBC#GeneTherapy#AAV